| Extracellular matrix structure AD Theocharis, SS Skandalis, C Gialeli, NK Karamanos Advanced drug delivery reviews 97, 4-27, 2016 | 3137 | 2016 |
| Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting C Gialeli, AD Theocharis, NK Karamanos The FEBS journal 278 (1), 16-27, 2011 | 2082 | 2011 |
| A guide to the composition and functions of the extracellular matrix NK Karamanos, AD Theocharis, Z Piperigkou, D Manou, A Passi, ... The FEBS journal 288 (24), 6850-6912, 2021 | 1097 | 2021 |
| Glycosaminoglycans: key players in cancer cell biology and treatment N Afratis, C Gialeli, D Nikitovic, T Tsegenidis, E Karousou, AD Theocharis, ... The FEBS journal 279 (7), 1177-1197, 2012 | 689 | 2012 |
| The extracellular matrix as a multitasking player in disease AD Theocharis, D Manou, NK Karamanos The FEBS journal 286 (15), 2830-2869, 2019 | 557 | 2019 |
| Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting AD Theocharis, SS Skandalis, GN Tzanakakis, NK Karamanos The FEBS journal 277 (19), 3904-3923, 2010 | 502 | 2010 |
| Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics NK Karamanos, Z Piperigkou, AD Theocharis, H Watanabe, M Franchi, ... Chemical reviews 118 (18), 9152-9232, 2018 | 390 | 2018 |
| Syndecans–key regulators of cell signaling and biological functions NA Afratis, D Nikitovic, HAB Multhaupt, AD Theocharis, JR Couchman, ... The FEBS journal 284 (1), 27-41, 2017 | 334 | 2017 |
| Matrix modeling and remodeling: a biological interplay regulating tissue homeostasis and diseases NK Karamanos, AD Theocharis, T Neill, RV Iozzo Matrix Biology 75, 1-11, 2019 | 270 | 2019 |
| Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans SS Skandalis, N Afratis, G Smirlaki, D Nikitovic, AD Theocharis, ... Matrix Biology 35, 182-193, 2014 | 262 | 2014 |
| Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition AD Theocharis, ME Tsara, N Papageorgacopoulou, DD Karavias, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1502 (2), 201-206, 2000 | 219 | 2000 |
| Proteoglycans remodeling in cancer: Underlying molecular mechanisms AD Theocharis, NK Karamanos Matrix Biology 75, 220-259, 2019 | 217 | 2019 |
| Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells P Bouris, SS Skandalis, Z Piperigkou, N Afratis, K Karamanou, AJ Aletras, ... Matrix Biol 43 (1), 42-60, 2015 | 214 | 2015 |
| Insights into the key roles of proteoglycans in breast cancer biology and translational medicine AD Theocharis, SS Skandalis, T Neill, HAB Multhaupt, M Hubo, H Frey, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1855 (2), 276-300, 2015 | 186 | 2015 |
| Efficient TGFβ-induced epithelial–mesenchymal transition depends on hyaluronan synthase HAS2 H Porsch, B Bernert, M Mehić, AD Theocharis, CH Heldin, P Heldin Oncogene 32 (37), 4355-4365, 2013 | 183 | 2013 |
| Serglycin: at the crossroad of inflammation and malignancy A Korpetinou, SS Skandalis, VT Labropoulou, G Smirlaki, A Noulas, ... Frontiers in oncology 3, 327, 2014 | 179 | 2014 |
| The complex interplay between extracellular matrix and cells in tissues D Manou, I Caon, P Bouris, IE Triantaphyllidou, C Giaroni, A Passi, ... The extracellular matrix: Methods and protocols, 1-20, 2019 | 177 | 2019 |
| Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma AD Theocharis, DH Vynios, N Papageorgakopoulou, SS Skandalis, ... The international journal of biochemistry & cell biology 35 (3), 376-390, 2003 | 164 | 2003 |
| Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors OC Kousidou, TN Mitropoulou, AE Roussidis, D Kletsas, AD Theocharis, ... International journal of oncology 26 (4), 1101-1109, 2005 | 137 | 2005 |
| The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents AP Asimakopoulou, AD Theocharis, GN Tzanakakis, NK Karamanos In vivo 22 (3), 385-389, 2008 | 131 | 2008 |
Nikos KaramanosProfessor of Biochemistry, University of Patras, Department of Chemistry, GreeceVerified email at upatras.gr
